Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling
Molecular Cancer Therapeutics (2010) - Comments
pubmed: 20699227  doi: 10.1158/1535-7163.mct-10-0477  issn: 1538-8514  issn: 1535-7163 

Rupal S. Bhatt, Xiaoen Wang, Liang Zhang, Michael P. Collins, Sabina Signoretti, David C. Alsop, S. Nahum Goldberg, Michael B. Atkins, James W. Mier